Company profile: NorthX Biologics
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for biologics from concept to commercial manufacturing; process development upstream/downstream optimization and verification; biopharmaceutical testing (analytical development, method validation, stability); recombinant protein production (microbial and mammalian); viral vector and vaccine development/manufacturing for clinical and commercial stages; GMP/non-GMP plasmid DNA production.
Products and services
- Viral Vector Services: NorthX Biologics delivers end-to-end services for viral vectors and vaccines, including development and manufacturing for clinical and commercial stages
- Biologics CDMO Services: NorthX Biologics delivers comprehensive contract development and manufacturing for biologics, supporting projects from concept to commercial manufacturing at commercial-scale
- Plasmid DNA Production: NorthX Biologics produces GMP-compliant and non-GMP plasmid DNA for various applications, including gene therapies and vaccines
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NorthX Biologics
Liverpool ChiroChem
HQ: United Kingdom
Website
- Description: Provider of chiral small molecules for biotech/pharma R&D, offering specialist building blocks, fragments and screening compounds to enable small molecule drug discovery, plus ultra-large (1.4B), covalent (800k) and kinase-focused (4.5M) virtual libraries, DEL synthons, heterobifunctional linkers, and a parallel synthesis lab producing up to 5,000 compounds per month.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liverpool ChiroChem company profile →
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
Arranta Bio
HQ: United States
Website
- Description: Provider of contract development and manufacturing services, including GMP RNA solutions (plasmid, RNA, lipid nanoparticle production), biologics development and cGMP manufacturing, viral vector and live virus manufacturing, GMP cell and virus banking, and microbiome services developing and manufacturing live biotherapeutic products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arranta Bio company profile →
3P Biopharmaceuticals
HQ: Spain
Website
- Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NorthX Biologics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NorthX Biologics
2.2 - Growth funds investing in similar companies to NorthX Biologics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NorthX Biologics
4.2 - Public trading comparable groups for NorthX Biologics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →